Pattern and outcome of disease progression in phase I study of vemurafenib in patients with metastatic melanoma (MM).
K. B. Kim
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche/Genentech
Research Funding - Plexxikon; Roche
K. T. Flaherty
Consultant or Advisory Role - Roche/Genentech
P. B. Chapman
Consultant or Advisory Role - Roche
Research Funding - Roche
J. A. Sosman
Consultant or Advisory Role - Roche
Honoraria - Roche
A. Ribas
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche/Genentech
G. A. McArthur
Consultant or Advisory Role - Roche (U)
R. K. Amaravadi
No relevant relationships to disclose
R. J. Lee
Employment or Leadership Position - Roche
K. B. Nolop
Employment or Leadership Position - Plexxikon
Stock Ownership - Plexxikon
I. Puzanov
Consultant or Advisory Role - Roche